Table 2.
Observed incidence rate | Unadjusted IRR | Adjusted IRRa | ||||
---|---|---|---|---|---|---|
HS patients | Control patients | IRR (95% CI) | P‐value | IRR (95% CI) | P‐value | |
N = 1204 | N = 6020 | |||||
Total days of lost work | 18·37 | 7·72 | 2·38 (2·09, 2·71) | <0·001* | 2·29 (2·03, 2·59) | <0·001* |
Medically‐related absenteeism days | 7·75 | 4·14 | 1·87 (1·76, 2·00) | <0·001* | 1·83 (1·71, 1·95) | <0·001* |
Disability days | 10·62 | 3·58 | 2·97 (2·36, 3·73) | <0·001* | 2·79 (2·23, 3·49) | <0·001* |
CI, confidence interval; HS, hidradenitis suppurativa; IRR, incidence rate ratio; N, number. *P < 0·05. aModified CCI and health insurance plan were adjusted for in the models.